Search Results - "Spyridon, Konitsiotis"

Refine Results
  1. 1

    An Inertial-Based Wearable System for Monitoring Vital Signs during Sleep by Kontaxis, Spyridon, Kanellos, Foivos, Ntanis, Adamantios, Kostikis, Nicholas, Konitsiotis, Spyridon, Rigas, George

    Published in Sensors (Basel, Switzerland) (26-06-2024)
    “…This study explores the feasibility of a wearable system to monitor vital signs during sleep. The system incorporates five inertial measurement units (IMUs)…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Configurable Offline Sensor Placement Identification for a Medical Device Monitoring Parkinson's Disease by Kostikis, Nicholas, Rigas, George, Konitsiotis, Spyridon, Fotiadis, Dimitrios I

    Published in Sensors (Basel, Switzerland) (24-11-2021)
    “…Sensor placement identification in body sensor networks is an important feature, which could render such a system more robust, transparent to the user, and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study by Kaltsonoudis, Evripidis, Zikou, Anastasia K, Voulgari, Paraskevi V, Konitsiotis, Spyridon, Argyropoulou, Maria I, Drosos, Alexandros A

    Published in Arthritis research & therapy (17-06-2014)
    “…The aim was to investigate the frequency of neurological adverse events in patients with rheumatoid arthritis (RA) and spondylarthropathies (SpA) treated with…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Clinical Evaluation in Parkinson's Disease: Is the Golden Standard Shiny Enough? by Kanellos, Foivos S, Tsamis, Konstantinos I, Rigas, Georgios, Simos, Yannis V, Katsenos, Andreas P, Kartsakalis, Gerasimos, Fotiadis, Dimitrios I, Vezyraki, Patra, Peschos, Dimitrios, Konitsiotis, Spyridon

    Published in Sensors (Basel, Switzerland) (01-04-2023)
    “…Parkinson's disease (PD) has become the second most common neurodegenerative condition following Alzheimer's disease (AD), exhibiting high prevalence and…”
    Get full text
    Journal Article
  8. 8

    Quality of Life and Emotional Strain in Caregivers of Patients with Multiple Sclerosis by Petrikis, Petros, Baldouma, Anastasia, Katsanos, Aristeidis H, Konitsiotis, Spyridon, Giannopoulos, Sotirios

    “…This study aimed was to measure the quality of life, fatigue, stress, and depression in a consecutive sample of caregivers of multiple sclerosis (MS) patients…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Voxel-Based Morphometry and Voxel-Based Relaxometry in Parkinsonian Variant of Multiple System Atrophy by Tzarouchi, Loukia C., Astrakas, Loukas G., Konitsiotis, Spyridon, Tsouli, Sofia, Margariti, Persefoni, Zikou, Anastasia, Argyropoulou, Maria I.

    Published in Journal of neuroimaging (01-07-2010)
    “…ABSTRACT BACKGROUND AND PURPOSE Multiple system atrophy (MSA) is a progressive neurodegenerative disorder divided into a parkinsonian (MSA‐P) and a cerebellar…”
    Get full text
    Journal Article
  17. 17

    An Emerging Problem in Clinical Practice: How to Approach Acute Psychosis by Markoula, Sofia, Chatzistefanidis, Dimitrios, Konitsiotis, Spyridon, Kyritsis, Athanassios P.

    Published in Clinics and practice (30-12-2011)
    “…Limbic encephalitis (LE) is rare, presents with memory impairment, seizures and behavioral disorder. We present a 44-year-old female with an…”
    Get full text
    Journal Article
  18. 18

    Action naming deficits in Parkinson's disease: the role of semantic complexity by Anyfantis, Emmanouil, Messinis, Lambros, Kambanaros, Maria, Konitsiotis, Spyridon

    Published in Aphasiology (02-04-2024)
    “…Previous studies have suggested that individuals with Parkinson's disease (PD) have difficulty retrieving verbs and nouns. Among the factors that have been…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Demyelination and other neurological adverse events after anti-TNF therapy by Kaltsonoudis, Evripidis, Voulgari, Paraskevi V, Konitsiotis, Spyridon, Drosos, Alexandros A

    Published in Autoimmunity reviews (01-01-2014)
    “…Abstract Tumor necrosis factor (TNF) α inhibitors are an essential therapeutic option for several inflammatory diseases, like rheumatoid arthritis,…”
    Get full text
    Journal Article